·PIB·15 marks·250–350 words

Discuss the challenges of enforcing pharmaceutical distribution-stage regulation in a federal setup where drug control is shared between the Centre and the States.

New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →
In this answer
  1. Challenges in enforcement
  2. Way forward

The Health Ministry has proposed adding Good Storage and Distribution Practices (GSDP) to the Drugs Rules, 1945. The aim is to keep a medicine's quality intact from the manufacturer to the patient. Central and State drug-control authorities would share enforcement [1]. The rule is sound, but it will be hard to enforce because of limited capacity and the way enforcement is split between the Centre and the States.

Challenges in enforcement

Administrative capacity

  • Too few inspectors: The Mashelkar Committee (2003) found too few trained staff at the Centre and in the States [3]. A Rajya Sabha Standing Committee (2007) pointed to the same shortage of drug inspectors and testing labs [4].
  • More premises to check: GSDP brings wholesalers, distributors and stockists under inspection [1]. It does not add any new inspector posts.

Federal unevenness

  • Uneven State capacity: Mashelkar linked weak State machinery to uneven drug quality across the country [3]. Two stockists under the same rule may face very different levels of checking depending on their State.
  • Split roles: The Centre sets the norms, while State inspectors carry most of the work at warehouses. This risks different readings of the same rule from State to State.

Enforcement built around factories

  • Risk-based inspections have targeted manufacturing units: 905 units inspected and 694 actions taken [2]. Warehouses have stayed outside this focus.
  • Who is to blame: A drug that fails a quality test (Not of Standard Quality, NSQ) leads to a recall order against the manufacturer [2]. The test cannot show whether the drug went bad in the factory or later, in a hot warehouse or truck.

Scale and a changing supply chain

  • A 2013 Parliamentary Standing Committee estimate put NSQ drugs at 7–8% and spurious drugs at 0.5% [3]. WHO warns that online sales are increasing falsified medicines [6]. The proposal does not name e-pharmacies or couriers [1].
  • Small stockists face compliance costs, such as temperature-controlled storage and record-keeping.

Way forward

  • States should create inspector posts based on workload, as Mashelkar urged [3]. The Centre did something similar in 2007 when it added 62 new Drug Inspector posts [4].
  • Drug controllers should take samples from wholesalers and stockists, not just factories, so test data can show where quality is lost.
  • CDSCO could offer a self-check modelled on WHO's GSDP Warehouse Rapid Assessment Tool [5], with phased deadlines for small stockists.
  • The final Rules should state clearly whether e-pharmacies and couriers are covered. The Drugs Consultative Committee can be used to keep enforcement uniform across States.

GSDP closes the regulatory gap between the factory and the patient, but its success depends on State capacity and Centre–State coordination. Cooperative federalism can make it work: common standards, funded State inspectorates and digital traceability. That would turn the right to health under Article 21 and SDG 3.8 (access to quality essential medicines) into a reality.

Sources

  1. 1PIB: Union Health Ministry proposes incorporating Good Storage and Distribution Practices into the Drugs Rules, 1945 (19 Nov 2026)GSDP scope, entities covered, shared Central–State enforcement
  2. 2PIB: Steps taken to Prevent Sale of Adulterated Drugs905 units inspected and 694 actions taken; NSQ alerts and manufacturer recalls
  3. 3PRS: Demand for Grants 2018-19 Analysis, Health and Family WelfareMashelkar Committee findings; NSQ 7–8% and spurious 0.5%
  4. 4Rajya Sabha Standing Committee Report on the Drugs and Cosmetics (Amendment) Bill, 2007 (PRS)shortage of drug inspectors and labs; 62 new posts
  5. 5WHO eManual: GSDP requirements / Warehouse Rapid Assessment Toolwarehouse self-assessment tool
  6. 6WHO Fact Sheet: Substandard and falsified medical productsonline sales spreading falsified medicines

More from this note